Eporal Interactions
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double
strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (TMP/SMX). During co-administration, systemic levels of TMP
and SMX were essentially unchanged. However, levels of dapsone and its metabolites increased in the presence of
TMP/SMX. Systemic exposure (AUC0-12) of dapsone and N-acetyl-dapsone (NAD) were increased by about 40% and
20% respectively in presence of TMP/SMX. Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine
(DHA) was more than doubled in the presence of TMP/SMX. Exposure from the proposed topical dose is about 1% of that
from the 100 mg oral dose, even when co-administered with TMP/SMX.
Certain concomitant medications (such as rifampin, anticonvulsants, St. Johnís wort) may increase the
formation of dapsone hydroxylamine, a metabolite of dapsone associated with hemolysis. With oral dapsone treatment,
folic acid antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic
reactions.
Eporal Contraindications
ACZONE™ Gel, 5%, is contraindicated in persons with a hypersensitivity to dapsone or any other component of the formulation.
Additional information about Eporal
Eporal Indication: For the treatment and management of leprosy and dermatitis herpetiformis.
Mechanism Of Action: Eporal acts against bacteria and protozoa in the same way as sulphonamides, that is by inhibiting the synthesis of dihydrofolic acid through competition with para-amino-benzoate for the active site of dihydropteroate synthetase. The anti-inflammatory action of the drug is unrelated to its antibacterial action and is still not fully understood.
Drug Interactions: Rifabutin Decreased levels of dapsone
Rifampin Decreased levels of dapsone
Trimethoprim Increased toxicity of both products
Aluminium Formation of non-absorbable complexes
Calcium Formation of non-absorbable complexes
Magnesium oxide Formation of non-absorbable complexes
Magnesium Formation of non-absorbable complexes
Food Interactions: Take without regard to meals.
Generic Name: Dapsone
Synonyms: P, P'-Sulfonyldianiline; P-Aminophenyl Sulfone; P,P-Sulphonyldianiline; P,P-Sulphonylbisbenzenamine; P,P-Sulphonylbisbenzamine; P,P-Sulfonylbisbenzenamine; P,P-Sulfonylbisbenzamine; P,P-Diaminodiphenyl Sulphone; P,P'-Diaminodiphenyl Sulfone; N, N'-Diphenyl Sulfondiamide; Metabolite C; Sulfonyldianiline; Sulphadione; Sulphonyldianiline; Diphenasone; Diaphenylsulphone; Diaphenylsulphon; Diaphenylsulfone; Diaphenylsulfon; Diaminodiphenyl Sulfone; Diaminodifenilsulfona; Dds, Pharmaceutical; Dds, Diaphenylsulfone; DDS; Dapsonum; Dapson; DADPS; Acedapsone; Diamino-diphenyl sulphone; DSS
Where to order Dapsone (and Eporal analogs) online:
Drug Category: Leprostatic Agents; Antimalarials; Anti-inflammatory Agents; Anti-Infectives; Antimycobacterials
Drug Type: Small Molecule; Approved
Other Brand Names containing Dapsone: Araldite Ht;
Avlosulfon;
Avlosulfone;
Avlosulphone;
Croysulfone;
Croysulphone;
Dimitone;
Diphone;
Dubronax;
Dumitone;
Eporal;
ICI;
Normet;
Novophone;
Recolip;
Sulfadione;
Sulfanona-Mae;
Sulfon-Mere;
Sulfona;
Sulfona-Mae;
Sulfone Ucb;
Sulphon-Mere;
Sumicure S;
Tarimyl;
Udolac;
Absorption: Bioavailability is 70 to 80% following oral administration.
Toxicity (Overdose): Overdosage might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken if necessary.
Protein Binding: 70 to 90%
Biotransformation: Hepatic, mostly CYP2E1-mediated.
Half Life: 28 hours (range 10-50 hours)
Dosage Forms of Eporal: Tablet Oral
Chemical IUPAC Name: 4-(4-aminophenyl)sulfonylaniline
Chemical Formula: C12H12N2O2S
Dapsone on Wikipedia: http://en.wikipedia.org/wiki/Dapsone
Organisms Affected: Mycobacteria